Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the EGFR Mutation Detection Test By RTPCR is typically 7-10 business days.

What are the prerequisites for the test EGFR Mutation Detection Test By RTPCR

  • Specimen: Formalin-fixed, paraffin-embedded tissue block or unstained slides
  • Specimen Size: Minimum of 5 slides or 1 block with tumor cells
  • Specimen Type: Non-decalcified tissue
  • Storage: Specimen should be stored at room temperature
  • Shipping: Specimen should be shipped at room temperature
  • Rejection Criteria: Decalcified tissue, inadequate specimen size, inappropriate storage or shipping conditions

What are the measure values for the test EGFR Mutation Detection Test By RTPCR

  • Test Name: EGFR Mutation Detection Test By RTPCR
  • Measure Values:
    • Wild-type EGFR: Negative
    • Exon 19 Deletion: Positive
    • L858R Mutation: Positive
    • T790M Mutation: Positive
    • Other Mutations: Positive

What does this test EGFR Mutation Detection Test By RTPCR identify?

EGFR Mutation Detection Test By RTPCR

This test is used to identify mutations in the EGFR gene through the Reverse Transcription Polymerase Chain Reaction (RTPCR) technique. The EGFR gene encodes a protein that is involved in cell growth and division. Mutations in this gene can lead to uncontrolled cell growth and are commonly found in certain types of cancer, particularly non-small cell lung cancer.

The EGFR Mutation Detection Test By RTPCR specifically looks for mutations in specific regions of the EGFR gene that are known to be associated with cancer. Identifying these mutations can help determine the most effective treatment options for patients with EGFR-mutated cancers.

Why is this test EGFR Mutation Detection Test By RTPCR taken?

EGFR Mutation Detection Test By RTPCR

Reasons for taking the EGFR Mutation Detection Test By RTPCR

The EGFR Mutation Detection Test By RTPCR is taken for several reasons:

  1. To guide treatment decisions: The test helps in determining the presence of specific mutations in the EGFR gene, which can help in selecting the most effective targeted therapy for patients with non-small cell lung cancer.
  2. To predict response to therapy: Patients with certain EGFR mutations may respond better to specific targeted therapies, such as EGFR tyrosine kinase inhibitors. The test can help predict which patients are likely to benefit from these treatments.
  3. To monitor disease progression: The test can be used to monitor the status of EGFR mutations over time, allowing healthcare providers to adjust treatment plans as needed based on changes in mutation status.
  4. To assess risk of resistance: Some EGFR mutations are associated with an increased risk of developing resistance to targeted therapies. The test can help identify these mutations early on, allowing for proactive management of resistance.

No FAQs available.

Customer Google Rating